Click on the logo to learn more about the study.
Durability II Study - www.legpainstudy.com
DEFINITIVE™ Ca++ Study – www.legpaintrial.com Study to evaluate the use of the SilverHawk™ Plaque Excision System and the SpiderFX Embolic Protection Device in the endovascular treatment of moderate to severely calcified femoropopliteal artery lesions.
DEFINITIVE™ LE Study A study designed confirm the value of plaque excision with the SilverHawk™ System.
|
Study of the investigational drug trans sodium crocetinate (TSC) in patients with Peripheral Arterial Disease (PAD) and leg pain with walking (intermittent claudication). |
This information is included for patient information only. The Vascular Disease Foundation does not endorse any clinical research studies.